Lexicon Pharmaceuticals, Inc. (LXRX) stock
LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)
Close on Nov 17, 2026Market cap $792.02MP/E –Yield –
Lexicon Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Lexicon Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -131.4%. For fiscal 2025 it was -98.2%, against -634.2% the year before. The highest annual figure on record is 43.9% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -98.2% | +536.0 |
| FY2024 | Dec 31, 2024 | -634.2% | +13630.7 |
| FY2023 | Dec 31, 2023 | -14265.0% | +58224.3 |
| FY2022 | Dec 31, 2022 | -72489.2% | −43264.4 |
| FY2021 | Dec 31, 2021 | -29224.8% | −29025.6 |
| FY2020 | Dec 31, 2020 | -199.2% | −243.1 |
| FY2019 | Dec 31, 2019 | 43.9% | +207.3 |
| FY2018 | Dec 31, 2018 | -163.4% | −20.9 |
| FY2017 | Dec 31, 2017 | -142.5% | +18.0 |
| FY2016 | Dec 31, 2016 | -160.5% | −161.6 |
| FY2015 | Dec 31, 2015 | 1.1% | +440.3 |
| FY2014 | Dec 31, 2014 | -439.2% | +4168.0 |
| FY2013 | Dec 31, 2013 | -4607.2% | +5348.3 |
| FY2012 | Dec 31, 2012 | -9955.5% | −3784.8 |
| FY2011 | Dec 31, 2011 | -6170.6% | −4220.4 |
| FY2010 | Dec 31, 2010 | -1950.2% | −1109.5 |
| FY2009 | Dec 31, 2009 | -840.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -3835.3% | −3848.2 |
| Q1 FY2026 | Mar 31, 2026 | -4.7% | +2030.1 |
| Q4 FY2025 | Dec 31, 2025 | -269.1% | −145.8 |
| Q3 FY2025 | Sep 30, 2025 | -85.9% | +3553.7 |
| Q2 FY2025 | Jun 30, 2025 | 12.9% | +3373.8 |
| Q1 FY2025 | Mar 31, 2025 | -2034.8% | +1977.0 |
| Q4 FY2024 | Dec 31, 2024 | -123.3% | +6534.4 |
| Q3 FY2024 | Sep 30, 2024 | -3639.6% | +26996.8 |
| Q2 FY2024 | Jun 30, 2024 | -3360.9% | +10594.9 |
| Q1 FY2024 | Mar 31, 2024 | -4011.8% | +125746.6 |
| Q4 FY2023 | Dec 31, 2023 | -6657.7% | +101478.0 |
| Q3 FY2023 | Sep 30, 2023 | -30636.4% | +28581.5 |
| Q2 FY2023 | Jun 30, 2023 | -13955.8% | +54635.6 |
| Q1 FY2023 | Mar 31, 2023 | -129758.3% | +51170.2 |
| Q4 FY2022 | Dec 31, 2022 | -108135.7% | −8300.9 |
| Q3 FY2022 | Sep 30, 2022 | -59217.9% | −51543.2 |
| Q2 FY2022 | Jun 30, 2022 | -68591.4% | +8590.1 |
| Q4 FY2021 | Dec 31, 2021 | -180928.6% | −177180.8 |
| Q3 FY2021 | Sep 30, 2021 | -99834.8% | −101141.3 |
| Q2 FY2021 | Jun 30, 2021 | -7674.8% | −6970.0 |
| Q1 FY2021 | Mar 31, 2021 | -77181.5% | −76400.9 |
| Q4 FY2020 | Dec 31, 2020 | -3747.7% | −3206.7 |
| Q3 FY2020 | Sep 30, 2020 | 1306.5% | +1230.2 |
| Q2 FY2020 | Jun 30, 2020 | -704.8% | −513.2 |
| Q1 FY2020 | Mar 31, 2020 | -780.6% | −591.0 |
| Q4 FY2019 | Dec 31, 2019 | -541.0% | −468.6 |
| Q3 FY2019 | Sep 30, 2019 | 76.3% | +405.4 |
| Q2 FY2019 | Jun 30, 2019 | -191.5% | +27.9 |
| Q1 FY2019 | Mar 31, 2019 | -189.6% | −40.9 |
| Q4 FY2018 | Dec 31, 2018 | -72.4% | +13.0 |
| Q3 FY2018 | Sep 30, 2018 | -329.1% | −225.8 |
| Q2 FY2018 | Jun 30, 2018 | -219.4% | +57.7 |
| Q1 FY2018 | Mar 31, 2018 | -148.6% | +71.3 |
| Q4 FY2017 | Dec 31, 2017 | -85.4% | +50.6 |
| Q3 FY2017 | Sep 30, 2017 | -103.4% | +22.7 |
| Q2 FY2017 | Jun 30, 2017 | -277.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -220.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -136.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -126.0% | – |
See a number that looks wrong?